Journal of the American College of Cardiology
Volume 62, Issue 25, Supplement, 24 December 2013, Pages D1-D3
IntroductionThe Fifth World Symposium on Pulmonary Hypertension
Under an Elsevier user license
open archive
Key Words
Fifth World Symposium
pulmonary arterial hypertension
pulmonary hypertension
Cited by (0)
Dr. Galiè has served on the advisory boards of and received lecture fees from Eli Lilly, Actelion, Pfizer, Bayer-Schering, GlaxoSmithKline, and Novartis; and has received institutional grant support from Actelion, Pfizer, Bayer-Schering, GlaxoSmithKline, and Novartis. Dr. Simonneau has served on the advisory boards of Eli Lilly, Actelion, Pfizer, Bayer-Schering, GlaxoSmithKline, and Novartis; has received lecture fees from Eli Lilly, Pfizer, Bayer-Schering, and GlaxoSmithKline; and has received institutional grant support from Actelion, Pfizer, Bayer-Schering, GlaxoSmithKline, and Novartis.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.